Biotech · Private company · New York, NY, US
Spark Neuro Inc.
Track this companyFree. Adds Spark Neuro Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- SPARK Cognitive Status Indicator (software support data collected via EEG)Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- SPARK TestAlzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Software Validation Study-Cognitive Status IndicatorNA · ENROLLING_BY_INVITATION · started Mar 31, 2025ClinicalTrials.gov NCT06809725 · fetched Nov 12, 2026
- EEG Diagnostic for Repetitive Sub-concussive Head ImpactsCOMPLETED · started Sep 23, 2022ClinicalTrials.gov NCT05562544 · fetched Nov 12, 2026
- The REMIND Study- SPARK Neuro Software StudyNA · COMPLETED · started May 18, 2022ClinicalTrials.gov NCT05406778 · fetched Nov 12, 2026
- Development of an EEG Diagnostic for Alzheimer's DiseaseCOMPLETED · started Oct 1, 2021ClinicalTrials.gov NCT04954183 · fetched Nov 12, 2026
NIH awards3
- Validation of a novel EEG-based neurodiagnostic platform for assessing cognitive impairment and Alzheimer's DiseaseFiscal year 2025 · $1.2MNIH RePORTER 5R44AG078039-03 · fetched Nov 12, 2026
- Validation of a novel EEG-based neurodiagnostic platform for assessing cognitive impairment and Alzheimer's DiseaseFiscal year 2024 · $1.3MNIH RePORTER 2R44AG078039-02 · fetched Nov 12, 2026
- Developing a novel EEG-based index for evaluating amyloid and tau burden in Alzheimer's DiseaseFiscal year 2024 · $1.2MNIH RePORTER 5R44AG080940-02 · fetched Nov 12, 2026